NEC voice recognition integrated with clinical trial app
Healthcare company CMIC Holdings has announced the development an iPhone app for clinical trials leveraging artificial intelligence voice recognition technology from NEC Corporation.
The app enables the huge amount of data required for clinical trials of drugs in development to be entered verbally to reduce the errors and omissions that occur when data is entered by hand, according to the announcement. This also reduces the amount of time researchers and supervisors are required to spend reviewing data.
The app, which was co-developed by CMIC and NEC, prevents access to the next data entry section until the previous one has been completed, and issues an audio warning if a data value outside an expected range is entered. The companies plan to further utilize the “NEC the WISE” AI portfolio for data analysis, and possibly to provide warnings of side affects and adherence issues.
A pilot program for the app began in March, 2018, with more than 50 Clinical Research Coordinators (CRCs) as part of CMIC’s Site Management Organization (SMO) program, and the program will be expanded to include CRCs across Japan in April.
NEC recently announced that its Integra ID 5 Multimodal Biometric Identification Solution is being utilized by the Los Angeles County Sheriff’s Department.
Comments